The landscape of dementia diagnosis has progressed radically with the appearance of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based checks which will detect Alzheimer's pathology a long time before indications emerge. While these technological advancements symbolize remarkable development in comprehending neurodegenerative health conditi... https://betteu864ufp4.corpfinwiki.com/user